TY - JOUR
T1 - Motherisk Rounds. The Effectiveness of Folate-Fortified Oral Contraceptives in Maintaining Optimal Folate Levels to Protect Against Neural Tube Defects
T2 - A Systematic Review.
AU - Shere, Mahvash
AU - Bapat, Priya
AU - Nickel, Cheri
AU - Kapur, Bhushan
AU - Koren, Gideon
N1 - Publisher Copyright:
© 2015 Society of Obstetricians and Gynaecologists of Canada.
PY - 2015
Y1 - 2015
N2 - Objective: To conduct a systematic review evaluating the effectiveness of a folate-fortified oral contraceptive preparation in increasing blood folate concentrations to levels providing optimal protection against neural tube defects (> 906 nmol/L).Methods: We searched Medline, EMBASE,Web of Science, and the Cochrane Library for human studies published from inception to June 2013 that evaluated oral contraceptive use and folate status. Case-control studies, cohort studies, and clinical trials were included. Efficacy and bioequivalence data were evaluated from included studies.Results: Overall, efficacy and bioequivalence data for the folate-fortified oral contraceptive show that it is at least as effective as folic acid alone in raising blood folate concentrations, and that the concomitant administration of folate with the oral contraceptive component does not affect its absorption or kinetics.Conclusion: A folate-fortified oral contraceptive preparation provides an option for women to maintain blood folate levels, especially those who may be planning a family after the cessation of oral contraceptive therapy.
AB - Objective: To conduct a systematic review evaluating the effectiveness of a folate-fortified oral contraceptive preparation in increasing blood folate concentrations to levels providing optimal protection against neural tube defects (> 906 nmol/L).Methods: We searched Medline, EMBASE,Web of Science, and the Cochrane Library for human studies published from inception to June 2013 that evaluated oral contraceptive use and folate status. Case-control studies, cohort studies, and clinical trials were included. Efficacy and bioequivalence data were evaluated from included studies.Results: Overall, efficacy and bioequivalence data for the folate-fortified oral contraceptive show that it is at least as effective as folic acid alone in raising blood folate concentrations, and that the concomitant administration of folate with the oral contraceptive component does not affect its absorption or kinetics.Conclusion: A folate-fortified oral contraceptive preparation provides an option for women to maintain blood folate levels, especially those who may be planning a family after the cessation of oral contraceptive therapy.
KW - Competing Interests: None declared
KW - Family planning
KW - Folate
KW - Oral contraceptive
KW - Pregnancy
KW - Prenatals
UR - http://www.scopus.com/inward/record.url?scp=84946235037&partnerID=8YFLogxK
U2 - 10.1016/S1701-2163(15)30229-2
DO - 10.1016/S1701-2163(15)30229-2
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 26334605
AN - SCOPUS:84946235037
SN - 1701-2163
VL - 37
SP - 527
EP - 533
JO - Journal of Obstetrics and Gynaecology Canada
JF - Journal of Obstetrics and Gynaecology Canada
IS - 6
ER -